Weekly nab-paclitaxel plus carboplatin as neoadjuvant therapy for IIIA-N2 lung squamous cell carcinoma: A prospective phase II study.

被引：1
|
作者：
Zhu, Jian-Quan
Zhang, Yu
Yue, Dongsheng
Zhao, Xiaoliang
Zhang, Qiang
Chen, Hui
Wang, Changli
机构：
[1] Tianjin Canc Hosp, Tianjin, Peoples R China
[2] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e20501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20501
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Weekly Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy for IIIA-N2 Lung Squamous Cell Carcinoma: A Prospective Phase II Study
    Zhang, Y.
    Zhu, J. Q.
    Yue, D.
    Zhao, X.
    Zhang, Q.
    Chen, H.
    Wang, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S314 - S314
  • [2] Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single Center
    Zhu, Jianquan
    Zhang, Yu
    Wang, Meng
    Zhang, Zhenfa
    Yue, Dongsheng
    Liu, Shichang
    Pan, Yi
    Wang, Changli
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [3] Carboplatin plus nab-paclitaxel for recurrent small cell lung cancer: A phase II study
    Ikeda, Naoya
    Arai, Ryo
    Soda, Sayo
    Inoue, Takashi
    Uchida, Nobuhiko
    Nakamura, Yusuke
    Masawa, Meitetsu
    Kushima, Yoshitomo
    Okutomi, Hiroaki
    Takemasa, Akihiro
    Shimizu, Yasuo
    Niho, Seiji
    THORACIC CANCER, 2022, 13 (09) : 1342 - 1348
  • [4] Phase I/II Study of Carboplatin Plus Weekly Nab-Paclitaxel in Aged ≥75 Patients with Squamous-Cell Lung Cancer: TORG1322
    Zenke, Y.
    Niho, S.
    Umemura, S.
    Ishihara, M.
    Ochiai, R.
    Nogami, N.
    Hosomi, Y.
    Shimokawa, T.
    Tokito, T.
    Goto, Y.
    Miura, Y.
    Saito, H.
    Hida, N.
    Ikeda, S.
    Tanaka, H.
    Furuya, N.
    Misumi, T.
    Ohe, Y.
    Okamoto, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S302 - S302
  • [5] Phase I/II study of carboplatin plus weekly nab-paclitaxel in patients aged ≥75 years with squamous-cell lung cancer: TORG1322
    Zenke, Yoshitaka
    Niho, Seiji
    Umemura, Shigeki
    Ishihara, Masashi
    Seki, Nobuhiko
    Nogami, Naoyuki
    Hosomi, Yukio
    Shimokawa, Tsuneo
    Tokito, Takaaki
    Goto, Yasushi
    Miura, Yosuke
    Saito, Haruhiro
    Hida, Naoya
    Ikeda, Satoshi
    Tanaka, Hiroshi
    Furuya, Naoki
    Misumi, Toshihiro
    Yamanaka, Takeharu
    Ohe, Yuichiro
    Okamoto, Hiroaki
    LUNG CANCER, 2020, 146 : 182 - 188
  • [6] Phase II study of carboplatin plus weekly nab-paclitaxel in elderly patients with NSCLC:NJLCG1301
    Usui, Kazuhiro
    Miyauchi, Eisaku
    Sugawara, Shunichi
    Fukuhara, Tatsuro
    Saito, Heisuke
    Fujita, Yuka
    Kato, Terufumi
    Suzuki, Toshiro
    Inoue, Akira
    Ishinose, Masakazu
    ANNALS OF ONCOLOGY, 2015, 26 : 92 - 92
  • [7] Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab‐paclitaxel for non‐squamous non‐small cell lung cancer with malignant pleural effusion
    Motohiro Tamiya
    Akihiro Tamiya
    Hidekazu Suzuki
    Yoshihiko Taniguchi
    Kanako Katayama
    Shojiro Minomo
    Keiko Nakao
    Naoko Takeuchi
    Yoshinobu Matsuda
    Yujiro Naito
    Takayuki Shiroyama
    Norio Okamoto
    Kyoichi Okishio
    Toru Kumagai
    Shinji Atagi
    Fumio Imamura
    Tomonori Hirashima
    Investigational New Drugs, 2021, 39 : 1106 - 1112
  • [8] Comparison of neoadjuvant nab-paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma
    Yang, Yafan
    Li, Haomiao
    Chen, Xiankai
    Qin, Jianjun
    Li, Yong
    Shen, Yaxing
    Zhang, Ruixiang
    Kang, Xiaozheng
    Wang, Zhen
    Zheng, Qingfeng
    Luo, Peng
    Li, Yin
    He, Jie
    THORACIC CANCER, 2023, 14 (07) : 700 - 708
  • [9] Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion
    Tamiya, Motohiro
    Tamiya, Akihiro
    Suzuki, Hidekazu
    Taniguchi, Yoshihiko
    Katayama, Kanako
    Minomo, Shojiro
    Nakao, Keiko
    Takeuchi, Naoko
    Matsuda, Yoshinobu
    Naito, Yujiro
    Shiroyama, Takayuki
    Okamoto, Norio
    Okishio, Kyoichi
    Kumagai, Toru
    Atagi, Shinji
    Imamura, Fumio
    Hirashima, Tomonori
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (04) : 1106 - 1112
  • [10] Phase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinoma
    Fan, Yun
    Jiang, Youhua
    Zhou, Xinming
    Chen, Qixun
    Huang, Zhiyu
    Xu, Yanjun
    Gong, Lei
    Yu, Haifeng
    Yang, Haiyan
    Liu, Jinshi
    Lei, Tao
    Zhao, Qiang
    Mao, Weimin
    ONCOTARGET, 2016, 7 (31) : 50624 - 50634
12345